Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Rijal

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
International Journal of Otolaryngology|January 25, 2012
Epistaxis in visceral leishmaniasis with hematological correlationB Sigdel, S Bhandary, S Rijal
Nepal Medical College Journal : NMCJ|September 29, 2012
Errors on a handwritten cardex: is it time for a change?A Rijal, K Gautam, A S Rijal
Physical Review Letters|September 13, 2024
Dynamics of Polar Vortex CrystallizationS Rijal, Y Nahas, S Prokhorenko, et al.
JNMA; Journal of the Nepal Medical Association|March 31, 2006
Pott's spine and paraplegiaM P Gautam, P Karki, S Rijal, et al.
JNMA; Journal of the Nepal Medical Association|August 24, 2016
Extra and Intra-articular Synovial ChondromatosisR K Chaudhary, B Banskota, S Rijal, et al.
Singapore Medical Journal|November 24, 1999
Clinico-haematological and management profile of aplastic anaemia--a first series of 18 cases from NepalS P Sah, G A Raj, S Rijal, et al.
Nepal Medical College Journal : NMCJ|July 20, 2012
Will visceral leishmaniasis be eliminated from Nepal? A review of recent (1994-2006) control effortsG P Bhandari, M R Angdembe, S Rijal, et al.
Journal of Basic and Clinical Physiology and Pharmacology|July 2, 2021
The effect of chitosan type and drug-chitosan ratio on physical characteristics and release profile of ketoprofen microparticles prepared by spray dryingMuhammad A S Rijal, Hanah Masitah, Fanny Purvitasari, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|January 13, 2006
The economic burden of visceral leishmaniasis for households in NepalS Rijal, S Koirala, P Van der Stuyft, et al.
The Journal of the Association of Physicians of India|November 19, 2003
Orally effective drugs for kala-azar (visceral leishmaniasis): focus on miltefosine and sitamaquineH Sangraula, K K Sharma, S Rijal, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
International Journal of Otolaryngology|January 25, 2012
Epistaxis in visceral leishmaniasis with hematological correlationB Sigdel, S Bhandary, S Rijal
Nepal Medical College Journal : NMCJ|September 29, 2012
Errors on a handwritten cardex: is it time for a change?A Rijal, K Gautam, A S Rijal
Physical Review Letters|September 13, 2024
Dynamics of Polar Vortex CrystallizationS Rijal, Y Nahas, S Prokhorenko, et al.
JNMA; Journal of the Nepal Medical Association|March 31, 2006
Pott's spine and paraplegiaM P Gautam, P Karki, S Rijal, et al.
JNMA; Journal of the Nepal Medical Association|August 24, 2016
Extra and Intra-articular Synovial ChondromatosisR K Chaudhary, B Banskota, S Rijal, et al.
Singapore Medical Journal|November 24, 1999
Clinico-haematological and management profile of aplastic anaemia--a first series of 18 cases from NepalS P Sah, G A Raj, S Rijal, et al.
Nepal Medical College Journal : NMCJ|July 20, 2012
Will visceral leishmaniasis be eliminated from Nepal? A review of recent (1994-2006) control effortsG P Bhandari, M R Angdembe, S Rijal, et al.
Journal of Basic and Clinical Physiology and Pharmacology|July 2, 2021
The effect of chitosan type and drug-chitosan ratio on physical characteristics and release profile of ketoprofen microparticles prepared by spray dryingMuhammad A S Rijal, Hanah Masitah, Fanny Purvitasari, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|January 13, 2006
The economic burden of visceral leishmaniasis for households in NepalS Rijal, S Koirala, P Van der Stuyft, et al.
The Journal of the Association of Physicians of India|November 19, 2003
Orally effective drugs for kala-azar (visceral leishmaniasis): focus on miltefosine and sitamaquineH Sangraula, K K Sharma, S Rijal, et al.
Pageof 5